Extended Care in High-Risk Surgical Patient (EXCARE) Pathway in High-risk Surgical Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1720 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-30

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High risk surgical patients are subject to complications that impact rehabilitation time, overall mortality and costs. This project proposes the creation of a post-surgery care pathway called Extended Care in High-Risk Surgical Patients (EXCARE) in the form of coordinated multiprofessional actions dedicated to high-risk non-cardiac surgical patients with the aim of improving the postoperative outcomes. The proposed pathway comprises a range of actions that include individual patient-centered risk assessment by the Anaesthesia and Perioperative Medicine Service (SAMPE) Risk Model (30-day probability of death), specialized care in Post-Anesthetic and Intensive Care Units (ICU), and also in the surgical wards performed by the nursing, anesthesia, clinic and surgery teams.

This is a quasi-experiment in which the clinical effectiveness of the extended care will be analyzed using a before-and-after comparison, the primary outcome being 30-day surgical mortality and postoperative complications at day 7 defined by PostOperative Morbidity Survey (POMS), a reliable and valid survey of short-term postoperative morbidity in major elective surgery. POMS domains evaluated are: pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, haematological and wound complications.

Secondary outcomes include 30-day mortality, hospital length of stay, number of Rapid Response Team calls, unplanned postoperative ICU admission, surgical reintervention, failure to rescue and hospital readmission. High-sensitive cardiac troponin (hs-cTn) levels will be measured before surgery and daily until 48 hours postoperatively to identify patients with myocardial injury (defined as any hs-cTn concentration greater than the 99th-percentile upper reference limit).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Derivation and Validation of the Extended Care (Ex-Care) Model II

NCT05796024

Postoperative Complications

UNKNOWN

Prospective Validation of ExCARE Model for 30-Day Postoperative Mortality

NCT07293377

Postoperative Complications

COMPLETED

Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery

NCT01457586

Heart Diseases

UNKNOWN PHASE4

Prognostic Value of Exhaled Isoprene Levels for Morbidity and Functional Outcome in Cardiosurgical Patients

NCT06175429

Frailty Muscle Weakness Volatile Organic Compounds +1 more

RECRUITING

Ischemic Postconditioning in Cardiac Surgery

NCT01813968

Cardiac Surgery

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Strengths and Limitations: This is the first study to evaluate the implementation of surgical patient stratification using the SAMPE Risk Model, pioneering the creation of a multidisciplinary care pathway that involves nursing and medical teams, and can be consolidated as a future standard of assistance. The care bundle, using an objective risk communication tool, is expected to integrate the teams involved in the perioperative care, reducing the fragmentation of care and, consequently, postoperative complications. The study is designed to use historical controls (before and after) and is therefore inherently vulnerable to the biases of this design. It will be conducted in a single teaching hospital and referral centre that provides care to patients from across southern Brazil through the national unified health system centre, which can therefore limit its external validity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Complications Patient Care Team

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Quasi-experimental study, nonrandomized, pre-post intervention study

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EXCARE Pathway Group

The proposed pathway comprises a range of actions that include individual patient-centered risk assessment by the SAMPE Risk Model (30-day probability of death), specialized care in Post-Anesthetic and Intensive Care Units, and also in the surgical wards performed by the nursing, anesthesia, clinic and surgery teams.

Group Type EXPERIMENTAL

Postoperative Monitoring

Intervention Type BEHAVIORAL

Nursing and medical staff will monitor patients vital signs and clinical deterioration triggers twice as often as in previous ward care.

High-sensitivity cardiac troponin testing

Intervention Type DIAGNOSTIC_TEST

High-risk patients will have their high-sensitivity cardiac troponin tested preoperatively and daily for the first 48h postoperatively

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Postoperative Monitoring

Nursing and medical staff will monitor patients vital signs and clinical deterioration triggers twice as often as in previous ward care.

Intervention Type BEHAVIORAL

High-sensitivity cardiac troponin testing

High-risk patients will have their high-sensitivity cardiac troponin tested preoperatively and daily for the first 48h postoperatively

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age over 16 years;
* Classified as high-risk by the SAMPE Risk Model (30-day mortality \>5%);
* Underwent non-cardiac surgeries at the main operating room unit;
* Referred postoperatively to the postanesthesia care unit or intensive care unit.

Exclusion Criteria

* Patients undergoing procedures performed outside the operating room unit (outpatient, diagnostic, performed under local anesthesia);
* Patients undergoing cardiac surgery with cardiopulmonary bypass and / or referred to the cardiac ICU postoperatively;
* Patients undergoing organ transplantation;
* Low-risk patients (classified as \<5% probability of death within 30 days by the SAMPE Risk Model).

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No